Christopher G. Hayes Verrica Pharmaceuticals Inc. (VRCA) insider trading activity

Christopher G. Hayes is CHIEF LEGAL OFFICER of Verrica Pharmaceuticals Inc.. Currently has a direct ownership of 176,458 shares of VRCA, which is worth approximately $1.4 Million. The most recent transaction as insider was on Mar 17, 2025, when has been sold 4,315 shares (Common Stock) at a price of $0.65 per share, resulting in proceeds of $2,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 176K

66.83% 3M change

8.11% 12M change

Total Value Held $1.4 Million

Christopher G. Hayes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	SELL Open market or private sale	$2,804 $0.65 p/Share	4,315 Reduced 2.39%	176,458 Common Stock
Aug 27 2024	SELL Open market or private sale	$23,443 $2.46 p/Share	9,530 Reduced 8.27%	105,773 Common Stock
Aug 26 2024	SELL Open market or private sale	$69,646 $2.66 p/Share	26,183 Reduced 18.51%	115,303 Common Stock
Jul 23 2024	SELL Open market or private sale	$635 $6.98 p/Share	91 Reduced 0.06%	141,486 Common Stock
Jul 22 2024	SELL Open market or private sale	$152,841 $7.06 p/Share	21,649 Reduced 13.26%	141,577 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	40,000 Added 19.68%	163,226 Common Stock
Nov 15 2023	SELL Open market or private sale	$34,327 $2.97 p/Share	11,558 Reduced 8.58%	123,226 Common Stock
Nov 14 2023	SELL Open market or private sale	$64,873 $2.93 p/Share	22,141 Reduced 14.11%	134,784 Common Stock
Aug 24 2023	BUY Grant, award, or other acquisition	-	75,000 Added 32.34%	156,925 Common Stock
Jul 24 2023	SELL Open market or private sale	$163,200 $4.83 p/Share	33,789 Reduced 29.2%	81,925 Common Stock
Jul 21 2023	BUY Grant, award, or other acquisition	-	100,000 Added 46.36%	115,714 Common Stock
Jul 11 2022	BUY Open market or private purchase	$25,500 $3.4 p/Share	7,500 Added 32.31%	15,714 Common Stock
Jul 05 2022	BUY Open market or private purchase	$11,999 $2.1 p/Share	5,714 Added 41.03%	8,214 Common Stock
Jun 04 2021	BUY Open market or private purchase	$24,475 $9.79 p/Share	2,500 Added 50.0%	2,500 Common Stock

CGH

Christopher G. Hayes

CHIEF LEGAL OFFICER

West Chester, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRCA shares.

Notify only if

Value

Insider Trading

Get notified when an Verrica Pharmaceuticals Inc. insider buys or sells VRCA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verrica Pharmaceuticals Inc.

Track Activities on VRCA

Account